Researcher Database

HOSOKI RUMIKO

Department / Course College of Pharmaceutical Sciences Department of Pharmacy

Title / Position Professor

Papers
1.	2021	Spontaneous and Immune Checkpoint Inhibitor‑Induced Autoimmune Diseases: Analysis of Temporal Information by Using the Japanese Adverse Drug Event Report Database │ Clinical Drug Investigation │ 41 (7),pp.615-627 (Co-authored)
2.	2018	A proposal for improving the design of fracture studies involving new drugs for osteoporosis by reducing the number of patients, shortening the administration period, and minimizing disadvantages for patients in the placebo group. │ RSMP │ 8,pp.151-163 (Co-authored)
3.	1998	Pharmacological profiles of new orally active nonpeptide tachykinin NK1 receptor antagonists. │ Eur. J. Pharmacol. │ 341,pp.235-241 (Co-authored)
4.	1997	Enzyme inactivation of enkephalin neurotransmitters in the spinal cord of the neonatal rat. │ Neurosci. Res. │ 28,pp.261-267 (Co-authored)
5.	1997	Tachykinin receptors on motoneurons in the spinal cords of neonatal rats, gerbils and hamsters. │ Neuropeptides │ 31,pp.495-501 (Co-authored)
6.	1997	The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. │ Biochem. Biophys. Res. Commun. │ 237,pp.527-531 (Co-authored)
7.	1996	Phenoxybenzamine discriminates between two distinct populations of histamine H1-receptors in longitudinal muscle of guinea-pig ileum. │ J. Smooth Muscle Res. │ 32,pp.249-254 (Co-authored)
8.	1996	Some pharmacological properties of a newly synthesized 3-acetoxy-6-acetylthio-10-oxo-N-cyclopropylmethyldihydro-normorphine (KT-95). │ Archives int. Pharmacodyn. │ 331,pp.136-152 (Co-authored)
9.	1995	Pharmacological characterization of GR82334, a tachykinin NK1 receptor antagonists, in the isolated spinal cord of the neonatal rat. │ Eur. J. Pharmacol. │ 281,pp.49-54 (Co-authored)
10.	1995	Use of NK1 receptor antagonists in the exploration of physiological functions of substance P and neurokinin A. │ Can. J. Physiol. Pharmacol. │ 73,pp.903-907 (Co-authored)
11.	1994	Effects of RP 67580, a tachykinin NK1 antagonist, on a primary afferent-evoked response of ventral roots in the neonatal rat spinal cord. │ Br. J. Pharmacol. │ 113,pp.1141-1146 (Co-authored)
12.	1994	Involvement of enzymatic degradation in the inactivation of tachykinin neurotransmitters in neonatal rat spinal cord. │ Br. J. Pharmacol. │ 113,pp.310-316 (Co-authored)
13.	1993	Depression of primary afferent-evoked responses by GR71251 in the isolated spinal cord of the neonatal rat. │ Br. J. Pharmacol. │ 110,pp.1142-1148 (Co-authored)
14.	1993	Pharmacological properties of a slow C-fiber response induced by stimulation of greater splanchnic nerve in an isolated spinal cord-nerve preparation of the newborn rat. │ Regulat. Peptides │ 46,pp.285-286 (Co-authored)
15.	1993	Potentiating effect of peptidase inhibitors on a C fiber-evoked response in the isolated spinal cord preparation of the neonatal rat. │ Regulat. Peptides │ 46,pp.458-460 (Co-authored)
16.	1992	Enzymatic inactivation of tachykinin neurotransmitters in the isolated spinal cord of the newborn rat. │ Neurosci. Res. │ 15,pp.289-292 (Co-authored)
17.	1992	Inhibitory effects of human, porcine and rat galanin examined in the isolated spinal cord of the newborn rat. │ Biomedical Res. │ 13 (suppl.2),pp.325-328 (Co-authored)
18.	1992	The isolated spinal cord-skin preparation of the newborn rat and effects of some algogenic and analgesic substances. │ Eur. J. Pharmacol. │ 220,pp.111-117 (Co-authored)
19.	1987	Pharmacological evidence for the possible coexistence of multiple receptor sites for mammalian tachykinins in rabbit iris sphincter smooth muscle. │ Naunyn-Schmiedeberg's Arch. Pharmacol. │ 335,pp.290-295 (Co-authored)
20.	1985	Some characterization of the responses to substance P and other tachykinins in rabbit iris sphincter muscle. │ Japan. J. Pharmacol. │ 37,pp.159-165 (Co-authored)
21.	1984	Effect of clenbuterol, a new selective adrenoceptor stimulant, on the release of histamine and SRS-A from passively sensitized guinea-pig chopped lungs. │ Gen. Pharmacol. │ 15,pp.345-348 (Co-authored)